Prelude Therapeutics Incorporated (PRLD)

Prelude Therapeutics Statistics

Total Valuation

PRLD has a market cap or net worth of $49.84 million. The enterprise value is -$31.32 million.

Market Cap	49.84M
Enterprise Value	-31.32M

Important Dates

The last earnings date was Tuesday, May 6, 2025, before market open.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

PRLD has 56.46 million shares outstanding. The number of shares has increased by 12.64% in one year.

Current Share Class	43.61M
Shares Outstanding	56.46M
Shares Change (YoY)	+12.64%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	7.87%
Owned by Institutions (%)	19.52%
Float	18.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.57
Forward PS	n/a
PB Ratio	0.48
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.18, with a Debt / Equity ratio of 0.17.

Current Ratio	5.18
Quick Ratio	5.01
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -81.44% and return on invested capital (ROIC) is -50.07%.

Return on Equity (ROE)	-81.44%
Return on Assets (ROA)	-45.05%
Return on Invested Capital (ROIC)	-50.07%
Return on Capital Employed (ROCE)	-115.23%
Revenue Per Employee	$53,435
Profits Per Employee	-$975,779
Employee Count	131
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.34% in the last 52 weeks. The beta is 1.29, so PRLD's price volatility has been higher than the market average.

Beta (5Y)	1.29
52-Week Price Change	-76.34%
50-Day Moving Average	0.76
200-Day Moving Average	1.91
Relative Strength Index (RSI)	55.59
Average Volume (20 Days)	103,488

Short Selling Information

The latest short interest is 978,610, so 1.73% of the outstanding shares have been sold short.

Short Interest	978,610
Short Previous Month	2.26M
Short % of Shares Out	1.73%
Short % of Float	5.40%
Short Ratio (days to cover)	8.83

Income Statement

In the last 12 months, PRLD had revenue of $7.00 million and -$127.83 million in losses. Loss per share was -$1.68.

Revenue	7.00M
Gross Profit	7.00M
Operating Income	-139.98M
Pretax Income	-129.85M
Net Income	-127.83M
EBITDA	-138.20M
EBIT	-139.98M
Loss Per Share	-$1.68

Balance Sheet

The company has $99.07 million in cash and $17.92 million in debt, giving a net cash position of $81.15 million or $1.44 per share.

Cash & Cash Equivalents	99.07M
Total Debt	17.92M
Net Cash	81.15M
Net Cash Per Share	$1.44
Equity (Book Value)	103.18M
Book Value Per Share	1.83
Working Capital	82.62M

Cash Flow

In the last 12 months, operating cash flow was -$105.33 million and capital expenditures -$522,000, giving a free cash flow of -$105.85 million.

Operating Cash Flow	-105.33M
Capital Expenditures	-522,000
Free Cash Flow	-105.85M
FCF Per Share	-$1.87

Margins

Gross Margin	100.00%
Operating Margin	-1,999.67%
Pretax Margin	-1,826.10%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PRLD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.64%
Shareholder Yield	-12.64%
Earnings Yield	-256.49%
FCF Yield	-212.39%

Analyst Forecast

The average price target for PRLD is $4.50, which is 408.70% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.50
Price Target Difference	408.70%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	72.06%
EPS Growth Forecast (5Y)	-11.96%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PRLD has an Altman Z-Score of -6.23 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.23
Piotroski F-Score	1